Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,124,071
-
Share change
-
+301,157
-
Total reported value
-
$1,542,061,517
-
Put/Call ratio
-
92%
-
Price per share
-
$36.61
-
Number of holders
-
142
-
Value change
-
-$3,925,227
-
Number of buys
-
67
-
Number of sells
-
79
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q2 2021
As of 30 Jun 2021,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,124,071 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Logos Global Management LP, and Avoro Capital Advisors LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.